Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 10.5 Three-party Agreement
- 10.6 Alpex Collaboration and License Agreement
- 10.7 Consultant Service Agreement
- 10.8 Citius License Agreement
- 10.9 Agreement or Proposal
- 10.10 Suprenza Quality Agreement
- 10.11 Suprenza Quality Agreement
- 23.1 Consent Letter
- Download Excel data file
- View Excel data file
CTXR similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Amendment No. 1 to the Registration Statement on Form S-1 of Citius Pharmaceuticals, Inc. of our report dated December 29, 2014, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our Firm under the caption "Experts" in such Prospectus.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
October 16, 2015